Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The British Heart Foundation has awarded a total of £7.6 million to research programmes at the world-leading Burdon Sanderson Cardiac Science Centre in the Department of Physiology, Anatomy and Genetics

Awardees : Left to right Dr Sarah De Val (BHF Senior Fellow), Dr Duncan Sparrow (BHF Senior Fellow), Associate Professor Pawel Swietach (BHF Programme Director), BHF Professor Paul Riley, Director of Regenerative Medicine Centre, Professor Manuela Zaccolo (BHF Programme Director & Director of Cardiac Centre), Dr Lisa Heather (BHF Intermediate Fellow),  Dr Samira Lakhal-Littleton (BHF Intermediate Fellow) & Professor David Paterson (BHF Programme Director & Head of Department).  

The BHF investment highlights the excellent quality of research, at the forefront of cardiac science today, which is carried out at the Burdon Sanderson Cardiac Science Centre. Embedded in the Oxford Cardiovascular Science network, we are grateful to the BHF Centre for Research Excellence, led by Professor Hugh Watkins, for start-up funding which enabled some of our awards.

Professor David Paterson, Head of the Department of Physiology, Anatomy and Genetics, commented: ‘Cardiac science is one of the main research themes in the Department, and this current funding is testament to the quality of the work undertaken by the 90 scientists in the Burdon Sanderson Cardiac Science Centre’.

Read more (Department of Physiology, Anatomy, and Genetics website)

British Heart Foundation 

British Heart Foundation.jpg

Similar stories

Research programme tackling COVID-19 variants of concern receives funding boost

A gift from the Red Avenue Foundation will enable the expansion of a major research programme aimed at rapidly identifying and interrogating emerging COVID-19 variants.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.

Neutrophil molecular wiring revealed: transcriptional blueprint of short-lived cells

Researchers publish the first blueprint of transcriptional factors that control neutrophil-driven inflammation in Nature Immunology.

Daily contact COVID-19 testing for students effective at controlling transmission in schools

A study by the University of Oxford has found that daily testing of secondary school students who were in contact with someone with COVID-19 was just as effective in controlling school transmission as the current 10-day contact isolation policy.